Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection

ABSTRACT Background Multi‐cancer early detection (MCED) through a single blood test significantly advances cancer diagnosis. However, most MCED tests rely on a single type of biomarkers, leading to limited sensitivity, particularly for early‐stage cancers. We previously developed SPOT‐MAS, a multimo...

Full description

Saved in:
Bibliographic Details
Main Authors: Thi Hue Hanh Nguyen, Giang Hoang Vu, Tu Thi Nguyen, Tuan Anh Nguyen, Vu Uyen Tran, Luyen Thi Vu, Giang Thi Huong Nguyen, Nhat Duy Nguyen, Trung Hieu Tran, Van Thien Chi Nguyen, Thanh Dat Nguyen, Trong Hieu Nguyen, Dac Ho Vo, Thi Tuong Vi Van, Thanh Thi Do, Minh Phong Le, Le Anh Khoa Huynh, Duy Sinh Nguyen, Hung Sang Tang, Hoai‐Nghia Nguyen, Minh‐Duy Phan, Hoa Giang, Lan N. Tu, Le Son Tran
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.70575
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841543420830547968
author Thi Hue Hanh Nguyen
Giang Hoang Vu
Tu Thi Nguyen
Tuan Anh Nguyen
Vu Uyen Tran
Luyen Thi Vu
Giang Thi Huong Nguyen
Nhat Duy Nguyen
Trung Hieu Tran
Van Thien Chi Nguyen
Thanh Dat Nguyen
Trong Hieu Nguyen
Dac Ho Vo
Thi Tuong Vi Van
Thanh Thi Do
Minh Phong Le
Le Anh Khoa Huynh
Duy Sinh Nguyen
Hung Sang Tang
Hoai‐Nghia Nguyen
Minh‐Duy Phan
Hoa Giang
Lan N. Tu
Le Son Tran
author_facet Thi Hue Hanh Nguyen
Giang Hoang Vu
Tu Thi Nguyen
Tuan Anh Nguyen
Vu Uyen Tran
Luyen Thi Vu
Giang Thi Huong Nguyen
Nhat Duy Nguyen
Trung Hieu Tran
Van Thien Chi Nguyen
Thanh Dat Nguyen
Trong Hieu Nguyen
Dac Ho Vo
Thi Tuong Vi Van
Thanh Thi Do
Minh Phong Le
Le Anh Khoa Huynh
Duy Sinh Nguyen
Hung Sang Tang
Hoai‐Nghia Nguyen
Minh‐Duy Phan
Hoa Giang
Lan N. Tu
Le Son Tran
author_sort Thi Hue Hanh Nguyen
collection DOAJ
description ABSTRACT Background Multi‐cancer early detection (MCED) through a single blood test significantly advances cancer diagnosis. However, most MCED tests rely on a single type of biomarkers, leading to limited sensitivity, particularly for early‐stage cancers. We previously developed SPOT‐MAS, a multimodal ctDNA‐based assay analyzing methylation and fragmentomic profiles to detect five common cancers. Despite its potential, SPOT‐MAS exhibited moderate sensitivities for early‐stage cancers. This study investigated whether integrating hotspot mutations into SPOT‐MAS could enhance its detection rates. Method A targeted amplicon sequencing approach was developed to profile 700 hotspot mutations in cell‐free DNA and integrated into the SPOT‐MAS assay, creating a single‐blood draw workflow. This workflow, namely SPOT‐MAS Plus was retrospectively validated in a cohort of 255 non‐metastatic cancer patients (breast, colorectal, gastric, liver, and lung) and 304 healthy individuals. Results Hotspot mutations were detected in 131 of 255 (51.4%) cancer patients, with the highest rates in liver cancer (96.5%), followed by colorectal (59.3%) and lung cancer (53.7%). Lower detection rates were found for cancers with low tumor mutational burden, such as breast (31.3%) and gastric (41.9%) cancers. In contrast, SPOT‐MAS demonstrated higher sensitivities for these cancers (51.6% for breast and 62.9% for gastric). The combination of hotspot mutations with SPOT‐MAS predictions improved early‐stage cancer detection, achieving an overall sensitivity of 78.5% at a specificity of 97.7%. Enhanced sensitivities were observed for colorectal (81.36%) and lung cancer (82.9%). Conclusion The integration of genetic and epigenetic alterations into a multimodal assay significantly enhances the early detection of various cancers. Further validation in larger cohorts is necessary to support broader clinical applications.
format Article
id doaj-art-b9eb8d60212341b2b7c7cf9eb3cc1d5f
institution Kabale University
issn 2045-7634
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-b9eb8d60212341b2b7c7cf9eb3cc1d5f2025-01-13T13:22:39ZengWileyCancer Medicine2045-76342025-01-01141n/an/a10.1002/cam4.70575Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early DetectionThi Hue Hanh Nguyen0Giang Hoang Vu1Tu Thi Nguyen2Tuan Anh Nguyen3Vu Uyen Tran4Luyen Thi Vu5Giang Thi Huong Nguyen6Nhat Duy Nguyen7Trung Hieu Tran8Van Thien Chi Nguyen9Thanh Dat Nguyen10Trong Hieu Nguyen11Dac Ho Vo12Thi Tuong Vi Van13Thanh Thi Do14Minh Phong Le15Le Anh Khoa Huynh16Duy Sinh Nguyen17Hung Sang Tang18Hoai‐Nghia Nguyen19Minh‐Duy Phan20Hoa Giang21Lan N. Tu22Le Son Tran23Medical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamMedical Genetics Institute Ho Chi Minh VietnamABSTRACT Background Multi‐cancer early detection (MCED) through a single blood test significantly advances cancer diagnosis. However, most MCED tests rely on a single type of biomarkers, leading to limited sensitivity, particularly for early‐stage cancers. We previously developed SPOT‐MAS, a multimodal ctDNA‐based assay analyzing methylation and fragmentomic profiles to detect five common cancers. Despite its potential, SPOT‐MAS exhibited moderate sensitivities for early‐stage cancers. This study investigated whether integrating hotspot mutations into SPOT‐MAS could enhance its detection rates. Method A targeted amplicon sequencing approach was developed to profile 700 hotspot mutations in cell‐free DNA and integrated into the SPOT‐MAS assay, creating a single‐blood draw workflow. This workflow, namely SPOT‐MAS Plus was retrospectively validated in a cohort of 255 non‐metastatic cancer patients (breast, colorectal, gastric, liver, and lung) and 304 healthy individuals. Results Hotspot mutations were detected in 131 of 255 (51.4%) cancer patients, with the highest rates in liver cancer (96.5%), followed by colorectal (59.3%) and lung cancer (53.7%). Lower detection rates were found for cancers with low tumor mutational burden, such as breast (31.3%) and gastric (41.9%) cancers. In contrast, SPOT‐MAS demonstrated higher sensitivities for these cancers (51.6% for breast and 62.9% for gastric). The combination of hotspot mutations with SPOT‐MAS predictions improved early‐stage cancer detection, achieving an overall sensitivity of 78.5% at a specificity of 97.7%. Enhanced sensitivities were observed for colorectal (81.36%) and lung cancer (82.9%). Conclusion The integration of genetic and epigenetic alterations into a multimodal assay significantly enhances the early detection of various cancers. Further validation in larger cohorts is necessary to support broader clinical applications.https://doi.org/10.1002/cam4.70575cfDNAgenetic and epigenetic alterationshotspot mutationsMCED
spellingShingle Thi Hue Hanh Nguyen
Giang Hoang Vu
Tu Thi Nguyen
Tuan Anh Nguyen
Vu Uyen Tran
Luyen Thi Vu
Giang Thi Huong Nguyen
Nhat Duy Nguyen
Trung Hieu Tran
Van Thien Chi Nguyen
Thanh Dat Nguyen
Trong Hieu Nguyen
Dac Ho Vo
Thi Tuong Vi Van
Thanh Thi Do
Minh Phong Le
Le Anh Khoa Huynh
Duy Sinh Nguyen
Hung Sang Tang
Hoai‐Nghia Nguyen
Minh‐Duy Phan
Hoa Giang
Lan N. Tu
Le Son Tran
Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
Cancer Medicine
cfDNA
genetic and epigenetic alterations
hotspot mutations
MCED
title Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
title_full Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
title_fullStr Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
title_full_unstemmed Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
title_short Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
title_sort combination of hotspot mutations with methylation and fragmentomic profiles to enhance multi cancer early detection
topic cfDNA
genetic and epigenetic alterations
hotspot mutations
MCED
url https://doi.org/10.1002/cam4.70575
work_keys_str_mv AT thihuehanhnguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT gianghoangvu combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT tuthinguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT tuananhnguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT vuuyentran combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT luyenthivu combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT giangthihuongnguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT nhatduynguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT trunghieutran combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT vanthienchinguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT thanhdatnguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT tronghieunguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT dachovo combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT thituongvivan combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT thanhthido combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT minhphongle combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT leanhkhoahuynh combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT duysinhnguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT hungsangtang combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT hoainghianguyen combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT minhduyphan combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT hoagiang combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT lanntu combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection
AT lesontran combinationofhotspotmutationswithmethylationandfragmentomicprofilestoenhancemulticancerearlydetection